Literature DB >> 22984292

Health and labor supply in the context of HIV/AIDS: the long-run economic impacts on antiretroviral therapy().

Harsha Thirumurthy1, Joshua Graff Zivin.   

Abstract

Using longitudinal survey data collected in Kenya, this paper estimates the longer-term impacts of antiretroviral therapy (ART) on the labor supply of treated adults and their household members. Building upon previous work in Kenya, data collected from 2004-2006 indicate that early evidence on the short-run impacts of ART tends to be upheld over the long-term as well. The results show that the labor supply response among treated adults occurs rapidly and is sustained through the 3-year observation period in our study. These results underscore the strong relationship between health and labor supply that has been observed in other contexts.

Entities:  

Year:  2012        PMID: 22984292      PMCID: PMC3439817          DOI: 10.1086/666954

Source DB:  PubMed          Journal:  Econ Dev Cult Change        ISSN: 0013-0079


  28 in total

1.  Dramatic improvement in survival among adult Brazilian AIDS patients.

Authors:  Jose Ricardo P Marins; Leda F Jamal; Sanny Y Chen; Marilisa B Barros; Esther S Hudes; Aristides A Barbosa; Pedro Chequer; Paulo R Teixeira; Norman Hearst
Journal:  AIDS       Date:  2003-07-25       Impact factor: 4.177

2.  Health and schooling investments in Africa.

Authors:  T P Schultz
Journal:  J Econ Perspect       Date:  1999

3.  The impact of HIV/AIDS on labour productivity in Kenya.

Authors:  Matthew P Fox; Sydney Rosen; William B MacLeod; Monique Wasunna; Margaret Bii; Ginamarie Foglia; Jonathon L Simon
Journal:  Trop Med Int Health       Date:  2004-03       Impact factor: 2.622

4.  Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

Authors:  Kara Wools-Kaloustian; Silvester Kimaiyo; Lameck Diero; Abraham Siika; John Sidle; Constantin T Yiannoutsos; Beverly Musick; Robert Einterz; Kenneth H Fife; William M Tierney
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

5.  Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study.

Authors:  Motasim Badri; Stephen D Lawn; Robin Wood
Journal:  Lancet       Date:  2006-10-07       Impact factor: 79.321

6.  Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.

Authors:  R S Hogg; B Yip; K J Chan; E Wood; K J Craib; M V O'Shaughnessy; J S Montaner
Journal:  JAMA       Date:  2001-11-28       Impact factor: 56.272

7.  Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.

Authors:  Cynthia Firnhaber; Laura Smeaton; Nasinuku Saukila; Timothy Flanigan; Raman Gangakhedkar; Johnstone Kumwenda; Alberto La Rosa; Nagalingeswaran Kumarasamy; Victor De Gruttola; James Gita Hakim; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2010-10-18       Impact factor: 3.623

8.  No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa.

Authors:  Christopher J Gill; Davidson H Hamer; Jonathon L Simon; Donald M Thea; Lora L Sabin
Journal:  AIDS       Date:  2005-08-12       Impact factor: 4.177

9.  Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience.

Authors:  Serena P Koenig; Fernet Léandre; Paul E Farmer
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

Review 10.  Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox; Christopher J Gill
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  4 in total

1.  The economic benefits of high CD4 counts among people living with HIV/AIDS in Zambia.

Authors:  Nyasha Tirivayi; John R Koethe
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

2.  Antiretroviral therapy for the prevention of HIV transmission: what will it take?

Authors:  Margaret L McNairy; Wafaa M El-Sadr
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

3.  Effect of antiretroviral therapy on patients' economic well being: five-year follow-up.

Authors:  Sydney Rosen; Bruce Larson; Julia Rohr; Ian Sanne; Constance Mongwenyana; Alana T Brennan; Omar Galárraga
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

4.  Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis.

Authors:  Omar Galárraga; Burke Gao; Benson N Gakinya; Debra A Klein; Richard G Wamai; John E Sidle; Rebecca K Papas
Journal:  BMC Health Serv Res       Date:  2017-03-28       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.